Results 111 to 120 of about 526 (127)

Pachychoroid Neovasculopathy, Intravitreal Injection, and Implications for Aeromedical Decision Making

Aerospace Medicine and Human Performance
BACKGROUND: Optimal visual function is essential in aviation to ensure flight safety and mission effectiveness. Pachychoroid neovasculopathy is a relatively recently recognized clinical entity of choroidal neovascularization, belonging to the pachychoroid spectrum, for which intravitreal therapy (IVT) is the ...
Wei Yun Lily, Yang, Isaac Wei Jie, Chay, Hou Boon, Lim, Marcus Chiang Lee, Tan, Brian, See, Jason Weizheng, Low   +5 more
openaire   +2 more sources

Three-year outcome of photodynamic therapy combined with VEGF inhibitor for pachychoroid neovasculopathy

Graefe's Archive for Clinical and Experimental Ophthalmology
Long-term results of photodynamic therapy (PDT) combined with vascular endothelial growth factor (VEGF) inhibitors for pachychoroid neovasculopathy (PNV) are not yet clear.This study is a retrospective, observational case series. We retrospectively examined untreated PNV cases (22 cases, 22 eyes, mean age of 71.0 years) who underwent PDT therapy in ...
Ryo Obata, Shuichiro Aoki, Obata Ryo
exaly   +3 more sources

Pachychoroid neovasculopathy.

Archivos de la Sociedad Espanola de Oftalmologia, 2021
I A, Placinta, R, Castro-Seco, J, Díaz-Cascajosa   +2 more
openaire   +1 more source

Two-Year Results of a Treat and Extend Regimen with Aflibercept in Caucasian Patients with Pachychoroid Neovasculopathy

Seminars in Ophthalmology, 2023
Clara Monferrer Adsuara
exaly  

Progression of Pachychoroid Neovasculopathy into Aneurysmal Type 1 Choroidal Neovascularization or Polypoidal Choroidal Vasculopathy

Ophthalmology Retina, 2022
Jakob Siedlecki, Siegfried Priglinger, Nikolaus Luft   +2 more
exaly  

A comparative study of type 1 neovascularization: Neovascular age-related macular degeneration versus pachychoroid neovasculopathy

European Journal of Ophthalmology, 2022
Ozcan Kayikcioglu, Emin Kurt, Muhammed Altinisik   +2 more
exaly  

Long term results of three anti-vascular endothelial growth factor agents in pachychoroid neovasculopathy

Cutaneous and Ocular Toxicology, 2022
Aslan Aykut, Buḡra Karasu, Mert Kaskal   +2 more
exaly  

Pachychoroid neovasculopathy: A comparative review on pathology, clinical features, and therapy

European Journal of Ophthalmology, 2022
Brijesh Takkar, Pradeep Sagar, Shorya Azad   +2 more
exaly  

Comparison of Regional Differences in the Choroidal Thickness between Patients with Pachychoroid Neovasculopathy and Classic Exudative Age-related Macular Degeneration

Current Eye Research, 2021
Edward Kang, Jaeryung Oh, Young Ho Kim
exaly  

Detection of pachychoroid neovasculopathy with optical coherence tomography angiography versus dye angiography imaging

Photodiagnosis and Photodynamic Therapy, 2022
Xiongze Zhang, Feng Wen, Yongyue Su
exaly